IMITREX (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the IMITREX drug offered from GlaxoSmithKline LLC. This Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | sumatriptan |
SUBSTANCE NAME: | SUMATRIPTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-09-18 |
END MARKETING DATE: | 0000-00-00 |
IMITREX HUMAN PRESCRIPTION DRUG Details:
Item Description | IMITREX from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 1997-09-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0523_f797155f-7edf-4ccb-be60-890560311694 |
PRODUCT NDC: | 0173-0523 |
APPLICATION NUMBER: | NDA020626 |
Other SUMATRIPTAN Pharmaceutical Manufacturers / Labelers: